Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; the references it cites are not checked yet.

Serum metabolism of bradykinin and des-Arg9-bradykinin in patients with angiotensin-converting enzyme inhibitor-associated angioedema

Blais, Charles, Rouleau, Jean-Lucien, Brown, Nancy J, Lepage, Yves, Spence, David, Munoz, Claudio, Friborg, Jacques, Geadah, David, Gervais, Nicole, Adam, Albert · 1999 · Immunopharmacology

Abstract

Angioedema (AE) associated with angiotensin-converting enzyme inhibitors (ACEi) is a rare, but potentially life-threatening adverse reaction. Several studies have suggested that bradykinin (BK) is responsible for ACEi-induced AE, but the mechanism remains unclear. We investigated the metabolism of BK and des-Arg9-BK in the serum of 20 patients with a history of ACEi-associated AE and 21 control (C) subjects. Synthetic BK was incubated with the sera for various periods of time and residual BK and generated des-Arg9-BK were quantified by specific and sensitive enzyme immunoassays. No significant difference of half-life (t1/2) of both BK and des-Arg9-BK could be measured between C subjects and patients with AE (AE) in absence of ACEi. However, an analysis according to the prolonged (+) or not (-) t1/2 of des-Arg9-BK allowed a new stratification of C subjects and AE patients in four subgroups. The preincubation of sera with enalaprilat at a concentration inhibiting ACE significantly prevented the rapid degradation of BK and des-Arg9-BK in these four subgroups. In presence of ACEi, a subgroup (50%) of AE patients (AE + ) had a particularly significant rise of the t1/2 of des-Arg9-BK. Once ACE was inhibited, the concentration or the nature of the ACEi had no significant effect on the t1/2 of des-Arg9-BK. However, a test dilution of AE + sera with a control (C) serum showed that an enzyme defect rather than a circulating inhibitor could be responsible for the abnormal metabolism of…

Overview

Integrity signals

Registry

Crossref · 10.1016/s0162-3109(99)00133-2

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

The citation lists are queued

They are fetched later and appear here then.

References 28 · Cited by 78

Research works printed but not linked: 3

  1. Décarie, 1996, Serum interspecies differences in metabolic pathways of BK and [des-Arg9]BK: influence of enalaprilat, Am. J. Physiol., 270, H1340
  2. Moore, J.W., Pearson, R.G., 1981. Complex reactions. In: Moore, J.W., Pearson, R.G. (Eds.), Kinetics and Mechanism. Wiley, New York, pp. 284–296.
  3. White, G.C., Marder, V.J., Colman, R.W., Hirsh, J., Salzman, E.W., 1994. Approach to the bleeding patient. In: Colman, R.W., Hirsh, J., Marder, V.J., Salzman, E.W. (Eds.), Hemostasis and Thrombosis: Basic Principles and Clinical Practice. JB Lippincott, Philadelphia, pp. 1134–1147.

Metadata

Authors
Blais, C., Rouleau, J.-L., Brown, N. J., Lepage, Y., Spence, D., Munoz, C., Friborg, J., Geadah, D., Gervais, N., & Adam, A.
Affiliations
  • Université de Montréal (CA)
  • Montreal Heart Institute (CA)
  • Vanderbilt University Medical Center (US)
  • Robarts Research Institute (CA)
  • Hôpital Maisonneuve-Rosemont (CA)
Corresponding author
Adam, Albert
Venue
Immunopharmacology
Publisher
Elsevier BV
Published
1999-09
Volume
43
Issue
2-3
Pages
293-302
ISSN
0162-3109 (ISSN-L)
OpenAlex
W2016105079
Cited by
78
References
28
Citations by year
2025: 1 · 2024: 2 · 2021: 3 · 2020: 2 · 2018: 3 · 2017: 1 · 2016: 1 · 2015: 2 · 2014: 5 · 2013: 4 · 2012: 6
FWCI
3.92
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations
  • Immunopharmacology (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Merck Canada
  • Fonds de Recherche du Québec - Santé
Topics
  • Health Sciences › Medicine › Hematology › Coagulation, Bradykinin, Polyphosphates, and Angioedema
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Renin-Angiotensin System Studies
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pineapple and bromelain studies
Keywords
bradykinin, des-Arg9-bradykinin, bradykinin metabolism, bradykinin B1 receptor, enalaprilat, angiotensin-converting enzyme inhibition, inflammation
MeSH terms
Adult, Aged, Angioedema, Angiotensin-Converting Enzyme Inhibitors, Lysine Carboxypeptidase, Bradykinin, Dose-Response Relationship, Drug, Female, Half-Life, Humans, Male, Middle Aged

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Serum metabolism of bradykinin and des-Arg9-bradykinin in patients with angiotensin-converting enzyme inhibitor-associated angioedema. https://app.cochat.ai/papers/10.1016/s0162-3109(99)00133-2
The paper
Blais, C., Rouleau, J.-L., Brown, N. J., Lepage, Y., Spence, D., Munoz, C., Friborg, J., Geadah, D., Gervais, N., & Adam, A. (1999). Serum metabolism of bradykinin and des-Arg9-bradykinin in patients with angiotensin-converting enzyme inhibitor-associated angioedema. Immunopharmacology. https://doi.org/10.1016/s0162-3109(99)00133-2

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.